OneSkin, a skin longevity brand based on biotechnological research, has announced a $20 million Series A investment from growth equity firm Prelude Growth Partners. The investment was finalized last month and represents a transition for OneSkin to a new investor for continued development.
At the time of investment, OneSkin was not seeking additional capital; however, Prelude Growth Partners initiated contact to invest in the company. OneSkin took this opportunity to replace an early-stage investor with a partner better suited to support its current development phase. The transaction reflects Prelude Growth’s interest in the skin longevity sector and in OneSkin’s position within it.
Founded by female PhD scientists, OneSkin focuses on extending “skinspan” by maintaining skin health and functionality through scientific research targeting aging at the cellular level. Their method involves addressing senescent cells, which accumulate over time and are associated with inflammation, collagen degradation, and visible signs of aging. OneSkin developed a proprietary peptide, OS-01, specifically formulated to address aging cells and enhance skin behavior and appearance.
Prelude Growth Partners is a New York-based equity firm that invests in consumer brands led by founders. Its portfolio includes multiple female-founded businesses across various categories, including health and wellness, beauty and personal care, food and beverage, and consumer services.
OneSkin offers topical and supplement products, including OS-01 FACE, BODY, EYE, LIP, and HAIR, which have developed a consumer following and some recognisable supporters. Previous investors include Selva Ventures, Unilever Ventures, Plus Capital, 2Future, SOSV, Meta Planet, and Able Partners.
KEY QUOTES:
“We’re incredibly proud to welcome Prelude Growth Partners to the OneSkin family. Their team’s expertise in building modern consumer brands and their enthusiasm for our science-driven approach made this a natural fit. We weren’t looking for new capital — but their passion and belief in our vision made this an opportunity to expand our resources and work alongside people we deeply admire. We got ourselves a dream team!”
Carolina Reis Oliveira, PhD, Co-Founder and CEO of OneSkin
“OneSkin’s cutting edge science, novel proprietary technology, leadership in skin longevity, and compelling brand are truly unique in the category. We are extremely proud to have the opportunity to partner with Carolina, Alessandra and the team at OneSkin to support them in creating an iconic, powerhouse brand of the future.”
Alicia Sontag, Co-Founder and Managing Partner of Prelude Growth
